What is the market capitalization of Regentis Biomaterials Ltd.?

Regentis Biomaterials Ltd. (RGNT) has a market capitalization of approximately 9,167,499 USD.

Where can I buy RGNT in Canada?

RGNT can be purchased through any Canadian online broker including Wealthsimple, Questrade, Qtrade, or RBC Direct Investing.

RGNT

Regentis Biomaterials Ltd.

Regentis Biomaterials Ltd. (RGNT) is an Israel company in the healthcare sector, listed on AMEX. Market capitalization of 9 million USD (micro-cap).

Details

Price1.77 USD

Market cap9.17 M USD

Payout ratio0.00%

Debt / Equity25.23%

SectorHealthcare

Websiteregentis.co.il

Updated 3h ago

Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen for the treatment and regeneration of damaged or diseased tissue; and GelrinC, a cell-free and off-the-shelf hydrogel, which is in Phase II clinical trial for the treatment of cartilage injuries in the knee. The company was incorporated in 2004 and is based in Herzliya, Israel.